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Although there is considerable evidence for a strong genetic component to idiopathic autism, several genomewide
screens for susceptibility genes have been performed with limited concordance of linked loci, reflecting either
numerous genes of weak effect and/or sample heterogeneity. Because decreasing sample heterogeneitywould increase
the power to identify genes, the effect on evidence for linkage of restricting a sample of autism-affected relative
pairs to those with delayed onset (at age 136 mo) of phrase speech (PSD, for phrase speech delay) was studied. In
the second stage of a two-stage genome screen for susceptibility loci involving 95 families with two or more
individuals with autism or related disorders, a maximal multipoint heterogeneity LOD score (HLOD) of 1.96 and
a maximal multipoint nonparametric linkage (NPL) score of 2.39 was seen on chromosome 2q. Restricting the
analysis to the subset of families ( ) with two or more individuals having a narrow diagnosis of autism andnp 49
PSD generated a maximal multipoint HLOD score of 2.99 and an NPL score of 3.32. The increased scores in the
restricted sample, together with evidence for heterogeneity in the entire sample, indicate that the restricted sample
comprises a population that is more genetically homogeneous, which could therefore increase the likelihood of
positional cloning of susceptibility loci.
Autism/autistic disorder (MIM 209850) is a develop-
ment disorder characterized by three classes of symp-
toms, including impairments in communication and re-
ciprocal social interactions and repetitive or stereotyped
behaviors and interests (Rapin and Katzman 1998).
Twin studies have indicated that genetic factors play an
important role in the etiology of autism (Folstein and
Rutter 1977; Ritvo et al. 1985; Steffenburg et al. 1989;
Bailey et al. 1995). The concordance rate for monozy-
gotic twins is much higher than that of dizygotic twins.
In addition, family studies indicate that the recurrence
risk to siblings, estimated from multiple studies at
1%–3%, is profoundly higher than the risk to the gen-
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eral population, which is ∼.5–2/1,000 (Bolton et al.
1994; Szatmari et al. 1998). The mode of inheritance of
autism appears complex, and latent-class analyses sug-
gest that 3–10 genes may underlie the disorder (Pickles
et al. 1995), although an interpretation of at least one
genomewide linkage analysis has argued for 110 genes
underlying the disorder (Risch et al. 1999).
Several genomewide screens for autism-susceptibility
genes have recently been published (International Mo-
lecular Genetic Study of Autism Consortium [IMGSAC]
1998; Barrett et al. 1999; Philippe et al. 1999; Risch et
al. 1999; see also Ashley-Koch et al. 1999; Auranen et
al. 2000). In these screens, there was little overlap in the
highest linkage peaks. The first screen, by the IMGSAC
(1998), identified a peak on chromosome 7, where there
appears to be the greatest concordance of findings (re-
viewed in Folstein and Mankoski 2000). However, even
in those studies with some evidence for linkage to this
region, there are discrepancies in peak localization.
Furthermore, the evidence for linkage observed by the
IMGSAC has decreased at this location with additional
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Table 1
Demographics of Family Groups
NO. OF FAMILIES WITH PSD/





Individuals genotyped 231/383 273/439
Autistic males 82/134 90/145
Autistic females 16/35 16/35
Borderline autistic males 1/1 8/8
Borderline autistic females 0/0 1/1
Males with Asperger disorder 0/0 0/1
Females with Asperger disorder 0/0 0/2
Sib pairs 46/80 54/91
Sib trios 1/2 1/2
First-cousin pairs 2/2 2/2
NOTE.—Families were recruited if they had at least two members
affected with a suspected diagnosis of autism, pervasive development
disorder, or Asperger disorder. With written informed consent from
the parents, all potentially affected individuals were subsequently as-
sessed by the Autism Diagnostic Interview-Revised (ADI-R) (Lord et
al. 1994). Most assessments were conducted by ADI raters (including
C.J.S.) trained by Dr. Catherine Lord, at the University of Chicago.
Additional raters were trained by C.J.S., who has had extensive train-
ing with Dr. Lord and her group and has been credentialed as an off-
site trainer and as a “reliable rater” against which another’s reliability
can be assessed. All raters achieved reliability of 190% with either Dr.
Lord’s group or C.J.S. The families include those recruited by the
Autism Genetic Research Exchange (AGRE), by the Seaver Autism
Research Center, and collaboratively by AGRE and the Seaver Center.
ADI-R worksheets were reviewed, and diagnosis confirmed, by C.J.S.
PSD was defined as onset of phrase speech at age 136 mo and cor-
responded to question 13 on the ADI-R. For a family to be categorized
as having PSD, two or more members had PSD.
families (IMGSAC 2000). The next highest peak in the
IMGSAC study and the highest peaks in other stud-
ies—for example, on chromosome 16p (IMGSAC 1998),
13 (Barrett et al. 1999), 2q, 7q, 16p, and 19p (Philippe
et al. 1999), and 1p (Risch et al. 1999)—showed less
reproducibility between studies. These issues have led to
the suggestion that autism may involve extensive genetic
heterogeneity (Lamb et al. 2000) and/or many interact-
ing genes of weak effect (Risch et al. 1999). If so, it may
prove very difficult, with the methods of linkage analysis
and positional cloning, to use genomewide linkage anal-
ysis to identify susceptibility loci with the typical sample
size of 50–200 families.
Regardless of the actual number of genes involved in
autism, decreasing sample heterogeneity will increase the
likelihood of identifying genes. Sample heterogeneity
may be reduced by use of narrower inclusion criteria or
by identication of traits that are shared among sub-
groups of families. Identifying traits that tend to be
shared by family members—particularly by affected sib-
ling pairs—is a means of identifying useful subgroups
of families and may identify traits that have greater ge-
netic components. Two studies, both with !50 sibships,
have been published that identify Autism Diagnostic
Interview (ADI) (Lord et al. 1994) components, which
showed increased familiality. In one study (Spiker et al.
1994), familiality was observed in the repetitive behavior
domain, and in the second study (MacLean et al. 1999),
familiality was observed in impairments in nonverbal
communication and verbal/nonverbal status. In a recent
analysis of 136 sibling pairs with autism, strong evidence
was found for concordance between affected sibling
pairs for the severity of repetitive behaviors, the level of
deficits in nonverbal communication, the presence of
phrase speech, and the age at onset of phrase speech
(J. M. Silverman, C. J. Smith, J. Schmeidler, E. Hollander,
B. A. Lawlor, M. Fitzgerald, J. D. Buxbaum, K. Delaney,
P. Galvin, unpublished data). Any of these clinical traits
might be useful to subcategorize families for linkage
analysis. Families in which affected members demon-
strate greater deficits in these domains may be at greater
genetic risk for autism and/or may be genetically more
homogeneous.
On the basis of studies of traits in nonaffected mem-
bers of autistic probands’ families, the use of language
has been proposed as a means to segregate families with
autism for linkage (Folstein et al. 1999). More recently,
because of the presence of a gene involved in language
disorder on 7q (Fisher et al. 1998), near the peak of
linkage to autism observed in several studies, it has been
suggested that grouping families in subsets on the basis
of language may increase evidence for linkage to this
region (Folstein and Mankoski 2000). In one sample,
restricting analyses to families with phrase-speech delay
(PSD) and including as affected those parents who,
through self-reporting, had delayed onset of speech,
trouble learning to read, or persistent spelling difficulties,
did in fact increase evidence for linkage to 7q (Folstein
and CLSA 2000). On the basis of evidence for familiality
of age at onset of phrase speech (MacLean et al. 1999;
J. M. Silverman, C. J. Smith, J. Schmeidler, E. Hollander,
B. A. Lawlor, M. Fitzgerald, J. D. Buxbaum, K. Delaney,
P. Galvin, unpublished data), restricting analyses to fam-
ilies with PSD may be useful to decrease heterogeneity,
thereby increasing the power to identify susceptibility
loci throughout the genome.
In the current study, Autism Diagnostic Interview–
Revised (ADI-R) (Lord et al. 1994) criteria were used
to identify 95 families with affected relative pairs with
autism, borderline autism, or Asperger disorder (table
1). To be considered affected with autism, an individual
had to satisfy the prespecified cutoff scores in all three
symptom areas of the ADI-R and had to present with
evidence for onset of symptoms at age !36 mo (Lord et
al. 1994). Individuals who failed to meet the ADI-R
algorithm criteria for autism by no more than one point
in the social domain and either, but not both, the com-
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Table 2







SCORE PLOD HLOD a LOD HLOD a
1:
D1S2842 273.5 .66 1.17 .61 2.06 1.24 .46 1.40 .08
2:
D2S319 7.6 .02 1.20 .66 3.41 .55 .31 1.69 .04
D2S112 141.6 3.57 .39 .38 4.74 .44 .28 1.04 .14
D2S335 175.9 1.48 1.20 .58 5.98 .54 .26 1.59 .05
D2S364 186.2 1.80 2.25 .82 1.28 1.65 .46 2.45 .01
D2S325 204.5 3.26 .67 .47 5.52 .65 .29 1.52 .06
D2S2382 213.5 2.68 .35 .37 4.80 .66 .30 1.26 .10
3:
D3S1285 91.2 4.65 .32 .33 9.10 .12 .12 1.05 .14
D3S1278 129.7 5.50 .45 .34 6.76 .64 .27 1.44 .08
D3S1267 139.1 3.67 .96 .47 7.77 .67 .25 1.91 .03
D3S1292 146.6 9.74 .39 .27 10.67 .86 .25 1.24 .10
D3S1279 169.6 4.19 .34 .32 8.07 .46 .20 1.01 .15
5:
D5S406 11.9 .67 1.21 .60 2.29 1.46 .46 1.65 .05
D5S630 19.7 3.37 .62 .41 6.03 .73 .26 1.30 .09
6:
D6S309 14.1 2.73 .56 .44 4.44 .85 .32 1.65 .05
D6S264 179.1 2.64 .56 .16 3.56 .90 .39 1.12 .13
7:
D7S502 78.7 1.95 .45 .42 4.83 .47 .03 1.30 .09
D7S684 147.2 4.23 .75 .45 6.09 .63 .28 1.53 .06
8:
D8S550 21.3 4.18 .74 .46 6.69 .64 .27 1.59 .05
D8S270 103.7 4.08 .31 .33 6.97 .38 .22 1.12 .13
9:
D9S1817 59.3 2.37 .44 .43 6.94 .10 .12 1.04 .14
D9S175 70.3 2.21 .51 .46 5.82 .31 .21 1.25 .10
D9S283 94.9 1.75 1.09 .56 3.98 1.09 .38 1.72 .04
D9S158 161.7 1.05 1.66 .80 1.16 1.89 .74 1.41 .07
11:
D11S987 67.5 5.03 .47 .35 6.91 .61 .28 1.13 .13
D11S1314 73.6 3.12 .65 .43 5.35 .74 .30 1.44 .07
D11S937 80.0 4.27 .73 .43 7.51 .36 .21 1.19 .11
17:
D17S1868 64.2 1.39 .69 .51 3.33 .87 .37 1.10 .13
19:
D19S216 20.0 4.72 .41 .36 5.31 .35 .32 1.06 .14
D19S226 42.3 2.60 .50 .40 5.68 .61 .25 1.13 .12
20:
D20S115 21.2 2.56 .54 .47 4.89 .52 .29 1.04 .15
NOTE.—Thirty-five first-stage families were genotyped with 382 autosomal ABI PRISM markers. Two-point LOD and HLOD (Smith 1963;
Durner and Greenberg 1992) scores were calculated under dominant or recessive models (Vieland et al. 1992b; Durner et al. 1999) at each
marker, with penetrance set at 50% (Greenberg et al. 1998) and with disease-allele frequencies arbitrarily set at .1 for recessive inheritance and
.006 for dominant inheritance. For HLOD analyses, the proportion of families with linkage (a) was also estimated. In addition, two-point NPL
scores were determined, along with associated P values. All genotyped family members were included in the analyses, and any individual not
receiving a research diagnosis of autism, borderline autism, or Asperger disorder was defined as phenotypically unknown. All analyses were
done with GENEHUNTER (Kruglyak et al. 1996). All markers demonstrating a LOD, HLOD, or NPL score 11.0 are shown. Of the 35 families
in the first-stage screen, 22 had PSD and 27 were in class 1.
munication or the repetitive-behavior domain were given
a research diagnosis of borderline autism. A diagnosis
of borderline autism was also given to individuals in
which all three domains were above threshold but the
onset criterion for autism was not met. A similar research
category has been used in another study (IMGSAC
1998). A research diagnosis of Asperger disorder was
given to those with neither autism nor borderline autism
but who met DSM-IV criteria for Asperger disorder. At
least one individual in each family had to satisfy ADI-
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Figure 1 Multipoint analyses of chromosome 2q. Multipoint LOD analyses under dominant (solid lines) and recessive (dashed lines)
modes of inheritance were performed (Vieland et al. 1992b; Durner et al. 1999), with penetrance set at 50% (Greenberg et al. 1998) and
allowing for locus heterogeneity (HLOD) (Smith 1963; Durner and Greenberg 1992). This simple approach works well for complex traits, even
if true modes of inheritance and numbers of genes contributing to the disease are not known (Vieland et al. 1992a, 1993). All genotyped family
members were included in the analyses, and any individual not receiving a research diagnosis of autism, borderline autism, or Asperger disorder
was defined as phenotypically unknown. Disease-allele frequency was arbitrarily set at .1 for recessive inheritance and .006 for dominant
inheritance. Multipoint linkage analyses using nonparametric estimates of sharing were also performed using NPL (dotted lines) with GENE-
HUNTER (Kruglyak et al. 1996).
R criteria for autism. In 84 families, a second individual
also met ADI-R criteria for autism (families in class I),
whereas in 8 families a second individual met criteria
for borderline autism, and in 3 families a second indi-
vidual met DSM-IV criteria for Asperger disorder (fam-
ilies in class II). Family studies suggest that genetic lia-
bility extends to other pervasive developmental disorders
and to Asperger disorder, and it has been argued that
including such individuals will not introduce significant
genetic heterogeneity (IMGSAC 1998).
A genetic screen was performed in two stages. In the
first stage, 35 families were genotyped with 382 ABI
PRISM markers (Linkage Marker Set MD-10, Applied
Biosystems) across the autosomes (∼10-cM density),
using a microcapillary-based ABI PRISM 310 Genetic
Analyzer. Using two-point analyses, we observed the
strongest evidence for linkage on chromosome 2q, at
marker D2S364 (heterogeneity LOD [HLOD] under
dominant, 2.25) (table 2). An adjacent marker also pro-
vided evidence for linkage (D2S335, HLOD under dom-
inant, 1.20). These markers, along with flanking mark-
ers, were then analyzed in the entire cohort ( ).np 95
Evidence suggestive of linkage was observed in the entire
sample on distal chromosome 2 by both parametric
(maximal multipoint HLOD scores [MMHLS] of 1.96)
and nonparametric (nonparametric linkage [NPL] score
of 2.39) methods (fig. 1, top left, and table 3, bottom
right). The estimate of families with linkage (a, table 3),
as well as the divergence between LOD scores and
HLOD scores (table 3), is suggestive of genetic hetero-
geneity in the sample.
In an attempt to narrow diagnostic criteria to reduce
heterogeneity, families in which there were two or more
members with autism (families in class I) and onset of
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Table 3
Multipoint Analyses of Chromosome 2q
With PSD Total
Families in Class I
Dominant 175.4 cM; 2.99 HLOD; a p .69 181.1 cM; 1.97 HLOD; a p .50
174.0 cM; 1.52 LOD 183.3 cM; 3.49 LOD;
Recessive 174.4 cM; 2.71 HLOD; a p .50 174.0 cM; 1.47 HLOD; a p .27
174.4 cM; 1.88 LOD; 172.6 cM; 13.21 LOD;
NPL 176.8 cM; Z-score p 3.32; P p 3.8 # 104 176.8 cM; Z-score p 2.47; P p 6.2 # 103
Families in Classes I and II
Dominant 179.0 cM; 2.62 HLOD; a p .61 183.3 cM; 1.96 HLOD; a p .48
181.2 cM; .30 LOD 183.3 cM; 4.54 LOD
Recessive 175.4 cM; 2.46 HLOD; a p .42 174.0 cM; 1.38 HLOD; a p .24
174.0 cM; 5.06 LOD; 174.0 cM; 18.05 LOD;
NPL 176.8 cM; Z-score p 3.17; P p 7.1 # 104 176.8 cM; Z-score p 2.39; P p 7.8 # 103
NOTE.—Multipoint LOD and HLOD scores were calculated under dominant or recessive models, as detailed
in the legend to figure 1. The peak score is indicated, along with its position and, for HLOD, the estimated
fraction of families with linkage (a). Multipoint NPL scores are also indicated, along with the position of
the peak, and associated P values.
phrase speech at age 136 mo were examined for evidence
of linkage. In the 49 families meeting these criteria, there
was increased evidence for linkage (MMHLS of 2.99
and NPL score of 3.32), compared with the results for
the entire cohort (fig. 1, bottom right, and table 3, top
left).
Further, exploratory analyses were performed to iden-
tify the determinants in the family groups that contrib-
uted to the increased evidence for linkage. Linkage anal-
ysis only in families in which there were two individuals
meeting ADI-R criteria for autism (families in class I,
), without a requirement for PSD, had little effectnp 84
on observed MMHLS and NPL scores (fig. 1, top right,
and table 3, top right), compared with analyses done on
the entire sample. In contrast, linkage analysis in the 57
families in classes I and II in which the affected family
members had PSD demonstrated more dramatic in-
creases in MMHLS and NPL scores (fig. 1, bottom left,
and table 3, bottom left), compared with analyses done
in the entire sample. These data indicate that limiting
analyses to families with PSD had a greater effect on the
evidence for linkage than limiting the study to families
in class I.
Evidence for heterogeneity decreased as more restric-
tive criteria were applied. Thus a, the estimate of families
with linkage, increased from 48% to 69%, using mul-
tipoint HLOD analyses under the dominant model, and
increased from 24% to 50%, using these analyses under
the recessive model (table 3). With evidence for greater
homogeneity in the families in class I with PSD, we per-
formed traditional multipoint LOD score analyses in this
sample (that is, we did not allow for heterogeneity).
Under a dominant model, maximal LOD score was 1.52
at 166.4 cM (table 3, top left). At this position, the LOD
score was 1.88 under a recessive model. In all other
subsets of the data, LOD scores were below zero in both
dominant and recessive models. The positive LOD score
in the most restricted sample suggests that there is in-
creased homogeneity in this subset of families.
To test for heterogeneity, we made use of the predi-
vided sample test (Morton 1956). LOD or HLOD scores
were compared between the entire sample, the most re-
stricted sample, and all families excluded from the most
restricted sample. For both the MMHLS and maximal
multipoint LOD score analyses, these comparisons pro-
vided significant evidence for heterogeneity ( ;2x p 6.31
, , and , ;2dfp 1 Pp .0120 x p 7.71 dfp 1 Pp
, respectively)..0054
The data in this study provide evidence suggesting
linkage to autism for a region on chromosome 2. It has
recently been reported that the IMGSAC, which had
previously found its highest LOD score on chromosome
7q (IMGSAC 1998), has found that, after additional
families were genotyped (for a total of 173), the highest
MLS scores were on chromosomes 9 (MLS 2.61), 16
(MLS 2.55), and 2 (MLS 2.33) (IMGSAC 2000). The
peak on chromosome 2 was localized to the same po-
sition as the peak we observed. In a recent scan involving
75 families, there is also weak evidence for linkage in
the same region (∼180 cM) (Barrett et al. 1999). In ad-
dition, in an unpublished study involving 99 families,
there was a peak (MLS 1.30 at 198.6 cM) on chro-
mosome 2 that overlapped with our peak (Bass et al.
2000). Although slightly distal, in a scan involving 51
families, two-point MLS analysis yielded scores of 0.98
and 0.65 at markers D2S382 (at 210 cM) and D2S364
(at 231.5 cM) (Philippe et al. 1999). In the current anal-
yses, there was increased evidence for linkage when the
analyses were restricted to those families in which af-
fected family members demonstrate PSD. Because the
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current analyses involved parametric analyses under two
models as well as grouping the data in subsets, the results
can only be taken as suggestive and require replication
in a separate group of families before evidence for link-
age will be compelling.
Several approaches have been considered in the autism
research community as means to improve the chances
of finding genes by positional cloning. These approaches
include narrowing the definition of affectedness to define
more genetically homogeneous groups and/or increasing
information by defining individuals with a broader
autism phenotype (Le Couteur et al. 1996; Piven et al.
1997) as affected. In the current study, the increase in
LOD and HLOD scores in the restricted sample with
PSD and the evidence for heterogeneity in the entire
sample indicates that narrower inclusion criteria may
result in decreased heterogeneity and may thereby in-
crease power to detect linkage in autism. Because it is
likely that autism-susceptibility genes result in a broader
autism phenotype in unaffected family members, a fur-
ther increase in power might be achieved in this restricted
sample by including as affected those individuals with
a broader autism phenotype.
In summary, the current results, when combined with
results from other groups, indicate that there may be an
autism-susceptibility gene on chromosome 2q. Further-
more, these results suggest that, if narrower inclusion
criteria are used, it may be possible to define a genetically
more-homogeneous group that could facilitate the po-
sitional cloning of putative autism-susceptibility genes.
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